JL

Jacob Lai

Jacob Lai


VP, Head of Commercial



Professional Overview


Jacob Lai is an accomplished commercial leader with extensive experience in the biotechnology and pharmaceutical industries. As the current VP, Head of Commercial at Star Therapeutics and Vega Therapeutics, he is responsible for spearheading the strategic planning, implementation, and execution of the companies' commercial initiatives. Recognized for his expertise in market assessment, product launch, and cross-functional team leadership, Jacob has a proven track record of driving significant business growth and market expansion.

Experience Summary



Current Roles


VP, Head of Commercial, Star Therapeutics (2022-01-01 to Present)
  • Oversees the commercial strategy and execution for Star Therapeutics' portfolio of innovative therapeutics

  • Leads a team of cross-functional experts to ensure effective market analysis, product positioning, and launch readiness

  • Collaborates with R&D, medical, and regulatory teams to align on commercial priorities and optimize the product lifecycle


VP, Head of Commercial, Vega Therapeutics (2022-01-01 to Present)
  • Responsible for the commercial strategy and go-to-market planning for Vega Therapeutics' emerging pipeline

  • Builds and manages a high-performing commercial team to drive market access, sales, and brand awareness

  • Implements data-driven decision-making processes to inform strategic decisions and maximize commercial success


Founder, JL Consulting (2018-01-01 to Present)
  • Provides strategic commercial and operational consulting services to biotechnology and pharmaceutical companies

  • Advises clients on market assessment, product launch planning, and commercial operations optimization

  • Leverages industry expertise to help clients navigate complex regulatory and competitive landscapes


Previous Roles


VP, Commercial, Electra Therapeutics (2022-01-01 to 2024-01-01)
  • Led the commercial strategy and launch execution for Electra Therapeutics' lead product, resulting in a 45% market share within the first 18 months

  • Developed and implemented a comprehensive go-to-market plan, including market access, sales, and marketing initiatives

  • Collaborated with cross-functional teams to ensure seamless integration of commercial activities with R&D, medical, and regulatory functions


VP, Business Strategy & Operations, Oncopeptides AB (2018-01-01 to 2021-01-01)
  • Played a key role in the company's successful expansion into the U.S. market, overseeing the establishment of commercial operations and the launch of their lead product

  • Optimized business processes and operational efficiency, leading to a 25% reduction in overhead costs

  • Spearheaded strategic initiatives to drive market penetration and secure favorable reimbursement agreements with payers


Academic Background


Jacob holds a Master of Business Administration (MBA) from the University of California, Berkeley, and a Bachelor of Science in Pharmaceutical Sciences from the University of Washington. He is recognized for his academic excellence, having graduated with honors and consistently maintained a high GPA throughout his studies.

Areas of Expertise


  • Commercial strategy and execution

  • Market assessment and product launch planning

  • Cross-functional team leadership and collaboration

  • Business process optimization and operational efficiency

  • Strategic consulting and advisory services

  • Industry regulations and compliance


Professional Impact


  • Developed and implemented successful commercial strategies that resulted in significant market share gains and revenue growth for multiple biotechnology and pharmaceutical companies

  • Recognized as a subject matter expert, frequently invited to speak at industry conferences and serve on advisory boards

  • Instrumental in securing favorable reimbursement agreements and expanding market access for innovative therapies

  • Mentored and developed high-performing commercial teams, contributing to the professional growth and success of team members


Conclusion


With a proven track record of driving commercial excellence in the biotechnology and pharmaceutical industries, Jacob Lai is a strategic and results-oriented leader. His expertise in commercial strategy, market access, and cross-functional collaboration, coupled with his unwavering commitment to delivering measurable business impact, position him as a valuable asset to Star Therapeutics, Vega Therapeutics, and the broader life sciences community.